Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.
Market size expected to reach $4.7 billion in 2027 CARLSBAD, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”)announced today they will be the...
Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock...
New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.54 | -13.3663366337 | 4.04 | 4.04 | 2.96 | 295951 | 3.17687208 | CS |
4 | -1.15 | -24.7311827957 | 4.65 | 4.6585 | 2.96 | 118862 | 3.41386275 | CS |
12 | -0.83 | -19.168591224 | 4.33 | 5.046 | 2.96 | 70655 | 3.81914716 | CS |
26 | -6.1 | -63.5416666667 | 9.6 | 11.5 | 2.96 | 1520109 | 5.95475293 | CS |
52 | -20.84 | -85.6203779786 | 24.34 | 29.435 | 2.96 | 3980719 | 15.50024258 | CS |
156 | -420.2 | -99.1739438282 | 423.7 | 760 | 2.96 | 1504457 | 48.92310434 | CS |
260 | -3621.5 | -99.9034482759 | 3625 | 3950 | 2.96 | 1772000 | 661.77071184 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관